Fig. 4: Risks of unspecified PASC diagnoses and Cognitive, Fatigue, and Respiratory symptom cluster among the SARS-CoV-2 infected pregnant women versus the matched infected non-pregnant women, in PCORnet and N3C cohorts. | Nature Communications

Fig. 4: Risks of unspecified PASC diagnoses and Cognitive, Fatigue, and Respiratory symptom cluster among the SARS-CoV-2 infected pregnant women versus the matched infected non-pregnant women, in PCORnet and N3C cohorts.

From: Long COVID after SARS-CoV-2 during pregnancy in the United States

Fig. 4: Risks of unspecified PASC diagnoses and Cognitive, Fatigue, and Respiratory symptom cluster among the SARS-CoV-2 infected pregnant women versus the matched infected non-pregnant women, in PCORnet and N3C cohorts.

Outcomes were ascertained 30 days after the first documented SARS-CoV-2 infection evidence until the end of the follow-up. The absolute risk, risk ratio, and risk difference were captured by the cumulative incidence (CIF), hazard ratio (HR), and the difference of cumulative incidence per 100 persons (DIFF/100), estimated at 180 days after the infection index date, respectively. The centers of the error bars were adjusted hazard ratios calculated by the Cox proportional hazard model, and error bars indicated two-sided 95% confidence intervals (95% CI).

Back to article page